NBY Novabay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.

$0.19  +0.00 (0.53%)
As of 05/26/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/26/2007
Outstanding shares:  52,618,364
Average volume:  407,180
Market cap:   $9,997,489
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -1.95
PB ratio:   0.57
PS ratio:   1.08
Return on equity:   -24.89%
Net income %:   -47.79%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy